NEXGEL, Inc. (NASDAQ:NXGL - Get Free Report) Director Scott Robert Henry sold 3,000 shares of the company's stock in a transaction on Friday, December 20th. The shares were sold at an average price of $4.64, for a total transaction of $13,920.00. Following the sale, the director now owns 144,553 shares of the company's stock, valued at $670,725.92. The trade was a 2.03 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
NEXGEL Stock Down 1.5 %
Shares of NEXGEL stock opened at $4.66 on Tuesday. NEXGEL, Inc. has a 12 month low of $1.84 and a 12 month high of $5.10. The business has a fifty day simple moving average of $3.38 and a 200 day simple moving average of $2.82. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19. The stock has a market cap of $31.65 million, a PE ratio of -8.03 and a beta of 0.76.
Institutional Trading of NEXGEL
A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. boosted its position in shares of NEXGEL, Inc. (NASDAQ:NXGL - Free Report) by 168.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,848 shares of the company's stock after purchasing an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned 0.50% of NEXGEL worth $82,000 as of its most recent SEC filing. 2.21% of the stock is currently owned by institutional investors.
NEXGEL Company Profile
(
Get Free Report)
Wall St. Icon: “If you wait on this, it will already be too late”
From InvestorPlace | Ad
If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.
Go here now to see my urgent warning
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
